Compare RPID & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPID | OPRX |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.3M | 222.6M |
| IPO Year | 2021 | 2008 |
| Metric | RPID | OPRX |
|---|---|---|
| Price | $4.31 | $7.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $8.00 | ★ $19.67 |
| AVG Volume (30 Days) | 190.3K | ★ 432.5K |
| Earning Date | 04-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.48 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $28,051,000.00 | ★ $92,127,000.00 |
| Revenue This Year | $19.91 | $19.77 |
| Revenue Next Year | $21.68 | $11.33 |
| P/E Ratio | ★ N/A | $777.00 |
| Revenue Growth | 24.57 | ★ 28.81 |
| 52 Week Low | $1.86 | $3.99 |
| 52 Week High | $4.94 | $22.25 |
| Indicator | RPID | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 30.49 |
| Support Level | $3.03 | N/A |
| Resistance Level | $4.46 | $14.45 |
| Average True Range (ATR) | 0.33 | 0.72 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 70.48 | 10.20 |
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.